Insulin vs Teriparatide
Overview
Insulin is primarily a weight management & metabolic peptide, while Teriparatide is used for bone & joint.
This page compares Insulin and Teriparatide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Insulin | Teriparatide | |
|---|---|---|
| Category | Weight Management & Metabolic | Bone & Joint |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | Highly individualized; type 1 diabetes basal-bolus regimens typically require 0.5–1.0 units/kg/day total; type 2 diabetes is often initiated with basal insulin at 10 units or 0.1–0.2 units/kg/day, titrated to individual glycemic targets | 20 mcg |
| Frequency | Once daily (long-acting basal analogs) to four or more times daily (basal-bolus or continuous subcutaneous insulin infusion); prandial doses given 0–15 minutes before meals for rapid-acting analogs or 30 minutes before meals for regular human insulin | daily |
| Reported benefits | Glycemic control, prevention of diabetic ketoacidosis, reduction of microvascular complications (retinopathy, nephropathy, neuropathy), life-sustaining therapy in type 1 diabetes, HbA1c reduction in type 2 diabetes | Bone density increase, osteoporosis treatment, fracture prevention |
| Reported side effects | Hypoglycemia, weight gain, injection-site lipohypertrophy, rare hypersensitivity reactions, peripheral edema at initiation | Dizziness, leg cramps, nausea |
Key differences
Primary use. Insulin is categorised under Weight Management & Metabolic, while Teriparatide falls under Bone & Joint. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Insulin: FDA-approved. Teriparatide: FDA-approved.
Dosing. Insulin is typically dosed at Highly individualized; type 1 diabetes basal-bolus regimens typically require 0.5–1.0 units/kg/day total; type 2 diabetes is often initiated with basal insulin at 10 units or 0.1–0.2 units/kg/day, titrated to individual glycemic targets (Once daily (long-acting basal analogs) to four or more times daily (basal-bolus or continuous subcutaneous insulin infusion); prandial doses given 0–15 minutes before meals for rapid-acting analogs or 30 minutes before meals for regular human insulin). Teriparatide is typically dosed at 20 mcg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Insulin and Teriparatide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Insulin and Teriparatide?
- Insulin is primarily a weight management & metabolic peptide, while Teriparatide is used for bone & joint. Insulin is FDA-approved for one or more indications, whereas Teriparatide is FDA-approved for one or more indications.
- What is Insulin used for?
- The foundational peptide hormone for glycemic management in type 1 and type 2 diabetes mellitus.
- What is Teriparatide used for?
- FDA-approved bone builder.
- Can you take Insulin and Teriparatide together?
- Some users combine peptides within a single protocol, but stacking Insulin and Teriparatide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Insulin or Teriparatide FDA-approved?
- Insulin is FDA-approved for one or more indications. Teriparatide is FDA-approved for one or more indications.
Read the full articles
- Insulin — full monograph: mechanism, research, dosing & references
- Teriparatide — full monograph: mechanism, research, dosing & references